RPG
AVNS

Risk Paradigm Group’s Avanos Medical AVNS Stock Holding History

Risk Paradigm Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1
Closed -$28 – 231
2015
Q3 		$28 Sell
1
-48
-98% -$1.67K ﹤0.01% 441
2015
Q2 		$1.99K Hold
49
– – ﹤0.01% 293
2015
Q1 		$2.41K Buy
+49
New +$2.27K ﹤0.01% 302

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Risk Paradigm Group's AVNS Position: Q4 2015 in Review

Risk Paradigm Group sold out of Avanos Medical (AVNS) in Q4 2015, closing a stake of 1 share — an estimated $28 sold.

Risk Paradigm Group first reported a position in AVNS in Q1 2015 and held it in 3 quarters. The position peaked at $2.41K in Q1 2015. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2015.

  • Risk Paradigm Group reported no remaining Avanos Medical position as of Q4 2015 after selling out during the quarter.
  • Risk Paradigm Group sold 1 Avanos Medical share in Q4 2015, an estimated $28.
  • Risk Paradigm Group first reported a position in Avanos Medical in Q1 2015 and held it in 3 quarters.
  • Risk Paradigm Group's Avanos Medical position peaked at $2.41K in Q1 2015.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2015.

Based on Risk Paradigm Group's 13F filing for Q4 2015, filed 10 Feb 2016.